Eturauhanen

https://www.degruyter.com/view/j/hmbci.ahead-of-print/hmbci-2017-0015/hmbci-2017-0015.xml ;Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction, new research concludes.